Search - tctmd.com

Displaying 161 - 180 of 648

Sort: Relevancy | Date

Risk Stratification and Treatment Goals of Acute PE

Presentation THT 2024

Risk Stratification and Treatment Goals of Acute PE

Presenter: Catalin Toma

March 06, 2024

Does Surgical or Catheter-Based Intervention Improve Outcomes for Patients with High-Risk Pulmonary Embolism on Veno-arterial Extracorporeal Membrane Oxygenation Compared to the Use of Anticoagulation Alone

Presentation THT Abstracts 2024

Does Surgical or Catheter-Based Intervention Improve Outcomes for Patients with High-Risk Pulmonary Embolism on Veno-arterial Extracorporeal Membrane Oxygenation Compared to the Use of Anticoagulation Alone

Presenter: Daniel Snyder

March 05, 2024

Factors Associated with Survival-to-Discharge in Patients with High-Risk Pulmonary Embolism Requiring Extracorporeal Membrane Oxygenation

Presentation THT Abstracts 2024

Factors Associated with Survival-to-Discharge in Patients with High-Risk Pulmonary Embolism Requiring Extracorporeal Membrane Oxygenation

Presenter: Robert Zilinyi

March 04, 2024

Clinical Presentation, Management, and Outcomes of Patients with Intermediate Risk Acute Pulmonary Embolism and Normotensive Shock.

Presentation THT Abstracts 2024

Clinical Presentation, Management, and Outcomes of Patients with Intermediate Risk Acute Pulmonary Embolism and Normotensive Shock.

Presenter: Robert Zilinyi

March 04, 2024

TCTMD’s Top 10 Most Popular Stories for February 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2024

March 01, 2024

AI Tools to Meet Every Need? The Future of Vascular Medicine

News Conference News ISET 2024

AI Tools to Meet Every Need? The Future of Vascular Medicine

February 02, 2024

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

News Conference News ISET 2024

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

January 30, 2024

Outpatient Management of Acute PE Remains Underused

News Daily News

Outpatient Management of Acute PE Remains Underused

January 29, 2024

AI Tools Can Flourish in CV Medicine, but Clinical Acumen Remains Key

News Conference News ISET 2024

AI Tools Can Flourish in CV Medicine, but Clinical Acumen Remains Key

January 23, 2024

GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks

News Daily News

GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks

January 21, 2024

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

News Daily News

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

January 02, 2024

Top Endovascular News of 2023

News Daily News

Top Endovascular News of 2023

December 28, 2023

Top Heart Rhythm News of 2023

News Daily News

Top Heart Rhythm News of 2023

December 26, 2023

AHA Updates Its Scientific Statement on CIED Infections

News Daily News

AHA Updates Its Scientific Statement on CIED Infections

December 11, 2023

High-Sensitivity Troponins May Overestimate PE Severity

News Daily News

High-Sensitivity Troponins May Overestimate PE Severity

November 28, 2023

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

November 20, 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

Case 3: High Risk Intermediate PE With Iliocaval DVT

Presentation TCT 2023

Case 3: High Risk Intermediate PE With Iliocaval DVT

Presenter: Sonal Pruthi

October 26, 2023

Case 2: Neurosurgical Patient With High Risk Intermediate PE

Presentation TCT 2023

Case 2: Neurosurgical Patient With High Risk Intermediate PE

Presenter: Sameer Khandhar

October 26, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.